Gallery
Photos from events, contest for the best costume, videos from master classes.
 |  |
 |  |
 |  |
 |  |
 |  |
 |  |
Claim Form Deadline: May 6, 2024 Payout: Varies Proof required: Yes What Is The Generic Drug Settlement About? An $85 million class action has been reached with Sun Pharmaceutical Industries and Taro Pharmaceuticals. The class action lawsuit claims that certain generic drug manufacturers broke antitrust laws, leading to artificially higher prices for common generic drugs such as amphetamine Claim deadline: July 21, 2025 Bronx Zoo ticket class action settlement – $990,000 A $990,000 settlement has been reached with the Wildlife Conservation Society over claims that it unlawfully charged processing fees for Bronx Zoo tickets purchased online. The manufacturers of the drug Neurontin reached a $325 million class action lawsuit settlement Wednesday over allegations they fraudulently marketed the prescription drug, which is used to treat seizures, restless leg syndrome, and pain caused by shingles. If approved, third-party payers of the drug will be eligible to claim a cash award from the Neurontin class action settlement, announced The Neurontin settlement marks the end to a nearly 10-year-old class action lawsuit battle in which plaintiffs, who included both direct purchasers and third-party payers, accused Pfizer of delaying generic versions of Neurontin and promoted the drug for unapproved uses. If you have suffered an injury after taking Neurontin, you may need to file a Neurontin lawsuit to get compensation. LegalMatch lawyers can help today. Los Angeles, CA: A $325 million preliminary settlement has been reached by Pfizer Inc and Warner-Lambert Co. LLC and plaintiffs who filed a consumer fraud class action lawsuit over the marketing A $190 million settlement has been reached in New York in a consumer fraud class action lawsuit pending against Pfizer which alleges the pharma giant engaged in tactics to delay market entry of generic versions of its epilepsy drug Neurontin. Neurontin Antitrust Litigation Claim Form Instructions This file provides instructions for submitting a claim related to the Neurontin antitrust litigation. It outlines the necessary steps for eligibility and participation in the settlement. Class members can ensure they receive their share of the net settlement fund by following these guidelines. Discover the latest on Gabapentin lawsuits, including settlements, payouts, and claims related to nerve damage, seizures, and off-label uses, with expert guidance on filing a case and seeking compensation for victims of this anticonvulsant medication. Pfizer Inc. has agreed to pay $325 million to resolve claims it defrauded insurers and other healthcare benefit providers by marketing Neurontin for unapproved uses. In the decade old class action lawsuit, TBS client, ASEA/AFSCME Local 52 Health Benefits Trust (ASEA), alleged that Pfizer and Warner-Lambert Co. sold Neurontin in an effort to boost profits Claim Form Deadline: April 17, 2025 Payout: $100 Million Total Fund Proof required: Varies What's the Walgreens Savings Club Class Action About? Walgreens has agreed to settle a $100 million class action lawsuit. The class action lawsuit alleges that Walgreens inflated its pharmacy drug prices by not considering the prices charged under its Prescription Savings Club, known as the Walgreens And it's the second settlement of Neurontin-related claims in less than 6 weeks. On April 21, Pfizer said it would pay $190 million to settle a federal antitrust lawsuit claiming that the company Neurontin Lawsuit | 2025 Latest Updates The prescription pain reliever Neurontin (generic gabapentin) has recently been linked to an increased risk for Stevens-Johnson syndrome (SJS), a severe skin disorder in which the top layer of the skin dies, followed by a painful rash that spreads and blisters. Pfizer Inc has agreed to pay $325 million to resolve claims it defrauded insurers and other healthcare benefit providers by marketing Neurontin for unapproved uses, its second settlement over the Consumers are filing lawsuits against prescription drug and medical device companies after facing serious injuries. Find out if you qualify for a lawsuit. Personal Injury Lawsuit Step by Step explained simply. Learn how to file, what to expect, and how to win. Step-by-step, Discover Gabapentin lawsuits information, including side effects, settlement claims, and lawsuit updates, to understand neurological damage, seizures, and addiction risks associated with the medication. Explore the potential for seeking compensation in gabapentin-related memory loss cases, including legal grounds, evidence, and filing deadlines. The settlement centered on Pfizer’s fraudulent marketing of Neurontin for off-label uses not approved by the Food and Drug Administration (FDA). Another significant case occurred in 2010 when the company agreed to pay $325 million to settle a class-action lawsuit brought by third-party payers. Neurontin Lawsuits Neurontin (generic name: gabapentin) was FDA-approved in 1993 for use as an anticonvulsant for people suffering from partial seizures associated with epilepsy.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
| |
| |
| |
| |
| |
| |